-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - (2) What is the evidence for harms? … Patient - how do women weigh the
benefits/harms of chemoprophylaxis?
b. … Harms to testing/
screening
Harms
Side effects
Adverse events
BB
CC
Population Interventions
Medication … Which factors predict who is most susceptible to harms of
therapy vs. benefits? … Strategies could be tested
that optimize benefits and minimize harms.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/unpublished-drug-trials-white-paper.pdf
December 01, 2024 - This can
lead to inflated efficacy estimates and underestimated harms or burdens, as unpublished studies … often document negative efficacy outcomes and/or harms. … investigational treatment does not demonstrate the expected benefit or improvement) or those
showing harms … Review
Project (DERP), we identified important discrepancies in the conclusions about the comparative
harms … Bias in the reporting of harms in clinical
trials of second-generation antidepressants
for depression
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
April 11, 2018 - Uncertainties relate to the benefits and harms of emerging
pharmacologic and non-pharmacologic treatments … , the benefits and harms of antibiotics
and systemic corticosteroids in mild AECOPD, the benefits and … view of trying to reduce prescriptions of antibiotics,
where safely possible, to reduce potential harms … In adult patients with mild acute exacerbation of COPD, what are the benefits and
harms of systemic … In adult patients with acute exacerbation of COPD, what are the benefits and harms
of combinations of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
July 01, 2010 - 2
Objective
To perform a comparative effectiveness review examining the benefits and harms … embolization in patients
with ACS who are undergoing PCI of native vessels and the various benefits and harms … and harms of those devices, we developed an analytic framework to map specific
linkages from comparisons … needed to assess for applicability (as specified in section F below), and prespecified
benefits and harms … followup
periods, improper definitions for
outcomes, composite end points
Outcomes (benefits and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-prevention_research-protocol.pdf
January 10, 2012 - Question 4
What are the harms of interventions for the prevention of pressure ulcers?
a. … Do the harms of preventive interventions differ according to the general category of
impairment the … Do the harms of preventive interventions differ according to setting
*
?
c. … Do the harms of preventive interventions differ according to patient characteristics
‡
? … /stage
o Resource utilization (e.g., length of stay and number of hospitalizations)
KQ 4:
o Harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
November 03, 2014 - It is
well established that specialists systematically rate the benefits and harms of treatment
more … In patients with acute gout, what are the benefits and harms of different
pharmacological therapies … Does effectiveness (benefits and harms) differ according to patient baseline
demographic characteristics … Does effectiveness (benefits and harms) differ according to disease severity,
including initial clinical … In adults with gout, what are the benefits and harms of different dietary therapies
and life style measures
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - harms, infections, cardiovascular events, cognitive harms, and
psychological harms (e.g., depression … gastrointestinal-related harms, cardiovascular-related harms, kidney-
related harms, falls, fractures … , motor vehicle accidents, endocrinological
A-3
harms, infections, cognitive harms, and psychological … harms (e.g.,
depression)? … Misuse, opioid use disorder, overdose and other harms
KQ2.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
February 01, 2019 - Five of 16 studies reported on harms and none were
clinically significant. … The same study did not report whether they looked
for or found harms of the interventions. … Of note, only one-quarter of the studies reported on harms. … Harms that were measured included death, hospitalization, and general adverse
events. … Assessing
harms when comparing medical interventions. 2008.
62.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias_methods.pdf
February 01, 2013 - and may overestimate benefits for oral
anticoagulants and underestimate
harms for short term effects … may exclude
large body of consistent studies that
may yield valuable information on
benefits or harms … , SRs should focus on assessing a range of patient-centered outcomes,
including both benefits and harms … The scope of included outcomes should address both
effectiveness and harms on which strength of the … AHRQ
series paper 4: assessing harms when
comparing medical interventions: AHRQ
and the effective
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
November 01, 2010 - Despite this increase in survival, both
immediate harms associated with HSCT (e.g., graft-versus-host … Second, comparative harms data are equally difficult to obtain, but further
separating out the harms … Is there an explanation of how harms were identified?
2. … Were harms attributed to the study intervention likely
causally associated?
6. … McMaster Quality Assessment Scale of Harms
(McHarm) for primary studies. 2005.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
January 01, 2013 - KQ 6: What are the harms associated with medical, laser, and other surgical treatments for open-angle … timolol in a RCT.5
Beta blocker prep
comparisons
One crossover study
showed no difference in
harms … • The profile of harms does not
differ between one- and two-site
combined cataract and glaucoma … New Evidence:
KQ6b: Harms Associated With Laser and Other Surgical Treatments for Open-Angle … • The profile of harms does not differ
between one- and two-site combined
New Evidence:
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-children_research-protocol.pdf
December 11, 2015 - An improved understanding of
the comparative benefits, harms, and modifiers of the available strategies … Key Question 2: What are the harms of these D/I/QI mental health strategies? … For KQ 2 and KQ 3
studies on moderators of harms, we will include experimental studies noted above, … We
identify studies that address KQ 3, moderators of strategy effectiveness or harms, as
those that … compare effectiveness or harms of a particular strategy between two or more
levels of the moderator
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
February 01, 2012 - Harms. What are the potential harms of
fecal DNA testing?
Figure A. … Analytic framework of the benefits and harms of fecal DNA testing
in screening for colorectal cancer … of
Screening
Screening
Harms of
Management/
Surveillance
Harms of
Treatment
4
5
6
3
2
b
a … We did not find any studies that specifically evaluated
the harms of fecal DNA testing. … The major hypothesized
harms of fecal DNA testing are the sequelae from
diagnostic inaccuracy (false
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
March 11, 2010 - Methods An important weakness in this report is not addressing false-positive
harms. … This is not a minimal issue as it is associated with over-
treatment harms. … I think that not including harms of overdiagnosis is a problem. … We have modified the paragraph to indicate that
there are harms associated with false-positive
exams … Results How are the authors defining some of these harms in the original
papers?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
November 13, 2014 - Studies specifically addressing treatment harms may also include retrospective
cohort studies. … We will assess harms as dichotomous variables to acknowledge the inherent
difficulties of assessing … harms, and also to simplify analysis. … There are various ways to
assess harms; each has problems. … The
non-pharmacologic interventions addressed in this review have a low incidence of harms.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
January 01, 2008 - prevalence of adverse events associated
with HSCT, a comprehensive review that focuses on both benefits and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
January 01, 2010 - on this topic would help to inform clinical practice surrounding the treatment
of RLS including any harms
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
August 01, 2022 - and proton radiation therapy, intra-operative radiotherapy) on ipsilateral breast
cancer outcomes, harms … Breast cancer recurrence,
short- and long-term harms
(e.g., Radiation Therapy
Oncology Group scores … Comparators Pre-operative imaging assessment for
PBI
WBI
Outcomes Cavity visualization score, harms … Cosmesis, treatment toxicities, other short- and long-
term harms (e.g., Radiation Therapy Oncology … Incorporates issues around both clinical
benefits and potential clinical harms
Yes
2d.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
May 01, 2013 - incorrectly
identified as being depressed, and potential adverse effects of labeling” as potential harms … but
found no evidence for any of these harms.19 Whether any of these harms is more likely when
screening … patients, providers,
and policymakers must consider the tradeoffs between the likely benefits and harms … Question 5
What are the comparative harms of screening for postpartum depression when compared to … of different strategies based on the literature review,
using the benefits and harms listed above.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
March 05, 2015 - Key
questions 3 (potential benefits and harms beyond symptoms of non-
HT agents) and 4 (analysis of … Authors should specifically note that this
review does not address the benefits and harms of available … In “Limitations of the Evidence Base on Other Benefits and Harms”
this seems like an ideal place to … It is unclear why the harms are depicted using a
different pathway (swervy line) rather than another … The wiggly line is convention to designate harms.